Douglas W. HathawayAssociateGreenberg Traurig, LLPWebsitewww.gtlaw.com/enOrganization ProfileFull ProfileBlogwww.gtlaw.com/en/insightsConnectEmailTwitterLinkedIn312-456-8447 Professional Biography Douglas W. Hathaway is a member of the Corporate Practice in Greenberg Traurig’s Chicago office. More Legal and Business Bylines From Douglas W. Hathaway 2023 Report on FINRA’s Examination and Risk Monitoring Program - (Posted On Tuesday, February 07, 2023) SEC Announces 2022 Examination Priorities - (Posted On Thursday, May 05, 2022) 2022 Report on FINRA’s Examination and Risk Monitoring Program - (Posted On Thursday, February 24, 2022) SEC Issues Risk Alert Regarding Registered Investment Companies - (Posted On Wednesday, November 03, 2021) Report on FINRA’s 2021 Examination and Risk Monitoring Program - (Posted On Thursday, February 18, 2021) Current Legal Analysis You See Health, Whistleblower Saw Fraud: Uncovering a $23 Million Healthcare Fraud Scheme by: Tycko & Zavareei Whistleblower Practice Group SCOTUS Takes Up Reverse Discrimination Framework Under Title VII by: Jennifer B. Rubin , Talia R. Weseley Wawrzenski v. United Airlines, Inc.: Key Takeaways for Employers Navigating Workplace Policies by: Morgan Forsey , Marissa Rael Cyber Resilience Act Published in the Official Journal of the EU by: Hunton Andrews Kurth’s Privacy and Cybersecurity Employers Are Extra Grateful This Thanksgiving After Federal Court Sets Aside DOL’s Salary Threshold Increase by: Theresa A. Topping Let’s Talk Compliance Episode 35: Let’s Talk Compliance: Physician Compensation Plans and Trends of 2024 [Podcast] by: Jana L. Kolarik Upcoming Events Dec 10 2024 Legal AI Week 2024 Nov 21 2024 CC&Rs and Easements for Mixed-Use Projects: Best Practices for Developers Nov 21 2024 AI Patent Eligibility: Processing the USPTO's New Guidance Nov 21 2024 Update of 2024 California Employment Law Cases Nov 25 2024 2024 Election: Impact on the Health Care Legal and Policy Landscape Webinar Dec 4 2024 TSCA 30/30 - December 4, 2024 Dec 4 2024 GLP-1 Drugs: What's Next after FDA's Resolution of Drug Shortages Dec 4 2024 REACH 30/30 - 04 December 2024 Print
